ReproCELL Incorporated (TYO:4978)
212.00
+5.00 (2.42%)
Aug 1, 2025, 3:30 PM JST
ReproCELL Employees
ReproCELL had 99 employees as of March 31, 2025. The number of employees increased by 3 or 3.13% compared to the previous year.
Employees
99
Change (1Y)
3
Growth (1Y)
3.13%
Revenue / Employee
30.08M JPY
Profits / Employee
1.04M JPY
Market Cap
20.07B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 99 | 3 | 3.13% |
Mar 31, 2024 | 96 | 4 | 4.35% |
Mar 31, 2023 | 92 | -6 | -6.12% |
Mar 31, 2022 | 98 | -8 | -7.55% |
Mar 31, 2021 | 106 | -7 | -6.19% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Chugai Pharmaceutical | 5,026 |
Daiichi Sankyo Company | 19,765 |
Takeda Pharmaceutical Company | 47,455 |
HOYA Corporation | 37,909 |
Otsuka Holdings | 35,338 |
Astellas Pharma | 13,643 |
Shionogi & | 4,955 |
Olympus | 29,297 |